Prof. Dr. Ikuro Suzuki – Pharmacology – Best Researcher Award

Posted on by Innovator Awards

Prof. Dr. Ikuro Suzuki - Pharmacology - Best Researcher Award

Tohoku Institute of Technology - Japan

Author Profile 

ORCID 

🎓 Early academic pursuits

Ikuro Suzuki began his scholarly journey at the prestigious university of tokyo, where he earned his ph.d. in march 2008 from the department of advanced interdisciplinary studies, graduate school of arts and sciences. during his doctoral research, he was awarded the esteemed dc1 research fellowship by the japan society for the promotion of science, reflecting his strong potential in advanced scientific exploration. this early phase of his academic development laid a solid foundation in cutting-edge technologies, including power electronics, biomedical engineering, and interdisciplinary innovation.

💼 Professional endeavors

After completing his doctoral studies, suzuki embarked on a dynamic academic career across several renowned institutions. he began as an assistant professor at the institute of biomaterials and bioengineering, tokyo medical and dental university (2008–2010), followed by another assistant professorship at the faculty of applied biological sciences, tokyo university of technology Pharmacology (2010–2014). in 2014, he joined the tohoku institute of technology, where he steadily rose through the ranks—first as a lecturer, then as an associate professor, and now as a full professor in the department of electrical and electronic engineering. concurrently, he has held influential roles including visiting researcher at riken and director of the air research institute.

🔬 Contributions and research focus

Professor suzuki's research integrates the fields of electrical engineering, biomedical systems, and intelligent electronics, with a strong focus on power electronics. his work bridges theory and practical innovation in electronic circuit design, control systems, and biomedical instrumentation. his multidisciplinary approach enables advancements in devices and technologies that Pharmacology support healthcare and automation. more recently, his research has included applications of power electronics in drug discovery systems and smart diagnostics, reflecting a seamless fusion of engineering and life sciences.

🌏 Impact and influence

Suzuki's influence extends beyond academic instruction into national and international research collaborations. his role as director of the air research institute has driven innovation in artificial intelligence and robotics, while his visiting researcher position at riken places him at the forefront of regenerative medicine and drug development technologies. by founding vitrovo inc. in Pharmacology 2023, he further demonstrated his commitment to translating academic innovation into commercial solutions, particularly in the context of advanced electronics and biotechnology. his work continues to contribute to advancements in power electronics and its applications in health tech.

📚 Academic cites

As an academic, suzuki has published numerous peer-reviewed papers in respected journals spanning electronic systems, biomedical engineering, and interdisciplinary science. his citations reflect a growing recognition of his work across fields, particularly in the application of intelligent control systems and power electronics to biomedical applications. his scholarly output is often referenced by peers working on next-generation devices and adaptive systems.

🧭 Legacy and future contributions

With a career that bridges academia, industry, and interdisciplinary innovation, professor ikuro suzuki's legacy lies in his integrative vision of engineering. as he continues to lead in education, research, and entrepreneurship, his future contributions are expected to focus on enhancing the functionality and intelligence of biomedical devices through power electronics, artificial intelligence, and compact embedded systems. he aims to mentor a new generation of engineers capable of navigating the convergence of electronics and life sciences.

Notable Publications 

  • Title: Development of a Microelectrode Array System for Simultaneous Measurement of Field Potential and Glutamate Release in Brain Slices
    Author(s): Aiko Hasegawa, Naoki Matsuda, Ikuro Suzuki
    Journal: Biosensors and Bioelectronics (2025-11)

  • Title: Advanced Neural Activity Mapping in Brain Organoids via Field Potential Imaging with Ultra-High-Density CMOS Microelectrodes
    Author(s): Remi Yokoi, Naoki Matsuda, Yuto Ishibashi, Ikuro Suzuki
    Journal: Preprint (bioRxiv), 2025-05-25

  • Title: Analysis of β Rhythm Induction in Acute Brain Slices Using Field Potential Imaging with Ultra-High-Density CMOS-Based Microelectrode Array
    Author(s): Hiroto Takahashi, Naoki Matsuda, Ikuro Suzuki
    Journal: Preprint (bioRxiv), 2025-04-04

  • Title: Development of a Microelectrode Array System for Simultaneous Measurement of Field Potential and Glutamate Release in Brain Slices
    Author(s): Aiko Hasegawa, Naoki Matsuda, Ikuro Suzuki
    Journal: Preprint (bioRxiv), 2025-04-04

  • Title: Field Potential Imaging in Human iPSC-Derived Cardiomyocytes Using UHD-CMOS-MEA
    Author(s): Naoki Matsuda, Nami Nagafuku, Kazuki Matsuda, Yuto Ishibashi, Tomohiko Taniguchi, Yusaku Matsushita, Norimasa Miyamoto, Takashi Yoshinaga, Ikuro Suzuki
    Journal: Preprint (bioRxiv), 2025-04-04

Mr. Rahul Pal – Pharmaceutics – Outstanding Scientist Award

Posted on by Innovator Awards

Mr. Rahul Pal - Pharmaceutics - Outstanding Scientist Award

Jagannath University, Chaksu, Jaipur, Rajasthan, India  - India 

Author Profile 

GOOGLE SCHOLAR 

🎓 Early academic pursuits

Rahul Pal began his academic journey with outstanding results during his formative years. he completed his high school and intermediate education from c. lal v. pal svm i.c., pilibhit, uttar pradesh, securing impressive marks of 83.83% and 86% respectively under the up board. his passion for pharmaceutical sciences became evident as he progressed to earn a bachelor of pharmacy (b. pharm) from invertis university, bareilly, u.p., with a cgpa of 8.27. furthering his education, he pursued a master of pharmacy (m. pharm) in pharmaceutics at nims university rajasthan, where he achieved a cgpa of 7.78. currently, rahul is enrolled in a ph.d. program in pharmaceutical sciences at chitkara university, punjab, beginning from december 2024 onwards.

💼 Professional endeavors

Rahul pal has demonstrated commendable commitment in academia. he started his teaching career as an assistant professor in the department of pharmaceutics at desh bhagat university (dbu), mandi gobindgarh, punjab. shortly after, he transitioned to the prestigious isf college of pharmacy, moga, serving as an assistant professor from august 2024 to april 2025. his dynamic involvement in academic institutions has been key to enriching the field of pharmaceutical sciences.

🔬 Contributions and research focus

rahul’s primary research interest lies in nanotechnology-driven drug delivery systems and their application in improving clinical outcomes. his work explores innovative pharmaceutical techniques, including power electronics-integrated drug formulation technologies, to optimize patient care. he has contributed to major scientific events such as national symposia and Pharmaceutics faculty development programmes, where he has delivered technical talks on ip rights, reputed journal identification, and advanced pharmaceutical systems. his invited lectures consistently emphasize the role of power electronics in automation and controlled drug delivery mechanisms.

🌍 Impact and influence

Rahul pal's influence in the field is evident through his invited speaker roles at multiple reputed national and international conferences. notably, he was invited to present at the world aquaculture, fisheries and seafood international conference (wac2025) in rome, italy, where he discussed the application of nanotechnology in fisheries and aquaculture, showcasing Pharmaceutics cross-disciplinary expertise. in addition, his presence in oral/poster judging panels reflects his recognition as an emerging authority in pharmaceutical academia.

🏆 Accolades and academic cites

Rahul received the prestigious young scientist award 2025 from the scientific laurels international committee, recognizing his promising contributions to the scientific community. his Pharmaceutics academic outputs and engagements have garnered attention on professional platforms like linkedin, and his expertise is increasingly cited in conferences and scholarly sessions across india and abroad. he has also been cited in symposiums that emphasize the integration of power electronics in biomedical innovation.

🔍 Legacy and future contributions

with a determined focus on bridging academia with industry and patient care, rahul pal is poised to shape the next era of pharmaceutical innovation. he aims to integrate power electronics, artificial intelligence, and nanoscience into advanced therapeutic solutions. through collaborative projects and cross-border conferences, he envisions establishing a globally recognized footprint in pharmaceutical nanotechnology. rahul’s long-term vision includes mentoring emerging researchers, contributing to policy framing, and pioneering patent-worthy innovations that transform healthcare systems globally.

Notable Publications 

  • Title: The Future Perspectives and Novel Approach on Gastro Retentive Drug Delivery System (GRDDS) with Current State
    Author(s): R. Pal, P. Pandey, L. Nogai, A. Anand, P. Suthar, M. SahdevKeskar, V. Kumar
    Journal: Journal of Population Therapeutics and Clinical Pharmacology

  • Title: The Advanced Approach in the Development of Targeted Drug Delivery (TDD) with Their Bio-Medical Applications: A Descriptive Review
    Author(s): R. Pal, P. Pandey, L. Nogai
    Journal: International Neurourology Journal

  • Title: The Pharmaceutical Polymer’s; A Current Status in Drug Delivery: A Comprehensive Review
    Author(s): R. Pal, P. Pandey, A. Anand, A. Saxena, S.K. Thakur, R.K. Malakar, V. Kumar
    Journal: Journal of Survey in Fisheries Sciences

  • Title: The Utilization of Response Surface Methodology (RSM) in the Optimization of Diclofenac Sodium (DS) Liposomes Formulate through the Thin Film Hydration (TFH) Technique
    Author(s): R. Pal, P. Pandey, M. Rizwan, M. Koli, S.K. Thakur, R.K. Malakar, H. Gupta, ...
    Journal: Journal of Advances in Medicine and Medical Research

  • Title: Design of Experiments (DoE) Manipulation in the Formulation and Optimization of a Traditional Ayurvedic Medicine Derived from Dried Extract of Senegalia catechu
    Author(s): P. Pandey, R. Pal, K.S. Bharath, A. Akilandeshwari, M. Koli, M. Rizwan, ...
    Journal: Journal of Pharmacognosy and Phytochemistry

Dr. Takeshi Yoshimoto – Cancer – Best Researcher Award

Posted on by Innovator Awards

Dr. Takeshi Yoshimoto - Cancer - Best Researcher Award

University of Tsukuba Hospital - Japan

Author Profile

SCOPUS

🎓 Early academic pursuits

 Dr. Takeshi Yoshimoto began his academic journey in the medical sciences with a strong foundation in clinical education. he earned his m.d. from hiroshima university faculty of medicine in march 2008, followed by a ph.d. from the graduate school of biomedical and health sciences, hiroshima university in august 2022. during his formative years, his curiosity about cerebrovascular diseases led him to explore genetics, biomarkers, and translational medicine, laying the groundwork for his future research focus, which indirectly intersects with diagnostic technologies resembling the precision systems used in power electronics.

🧠 Professional endeavors

Dr. Yoshimoto's career showcases a rich progression through esteemed institutions. from his early role as an intern at fukushima coop hospital, he gradually ascended through ranks at national cerebral and cardiovascular center, serving as resident, senior resident, Cancer and later as a medical doctor under  distinguished mentors like dr. ihara and dr. toyoda. he also contributed to academia at hiroshima university and currently serves as a lecturer in the department of stroke and cerebrovascular diseases at university of tsukuba hospital. his consistent clinical involvement paired with academic appointments underlines his dual commitment to patient care and neurological research.

🧬 Contributions and research focus

A pioneer in translational stroke research, dr. yoshimoto focuses on integrating genetics with acute stroke management. his primary research involves developing algorithms for selecting clot removal devices by identifying genetic variations, particularly the moyamoya-related rnf213 p.r4810k polymorphism. he explores the association between juvenile strokes and serum biomarkers. his projects are comparable in Cancer precision and application-oriented design to power electronics, highlighting his innovative integration of medical diagnostics and genetic profiling to improve acute care strategies.

🌍 Impact and influence

Dr. Yoshimoto’s work has had significant impact on cerebrovascular research, especially in japan. his dedication to exploring the genetic underpinnings of stroke has advanced understanding of moyamoya disease and enhanced patient stratification for endovascular therapy. his influence is also evident in the repeated recognition he received at prestigious national and international conferences, positioning him as a leading voice Cancer in neurovascular translational research. the framework he established for genetic-based intervention selection has potential parallels with feedback and adaptive systems in power electronics, reflecting the precision and personalization he brings to neurology.

🏆 Academic cites and recognition

Dr. Yoshimoto’s excellence has been widely acknowledged. he received the paul dudley white international scholar award from the american heart association in 2021 and multiple presentation awards at the japan stroke society and japanese society of neuroendovascular therapy (jsnet). notably, he received teaching awards and outstanding paper honors, reinforcing his role Cancer as both a scholar and mentor. these accolades validate the academic rigor and practical relevance of his work, particularly his contributions to stroke genetics and device selection.

🔬 Legacy and future contributions

Dr. Yoshimoto is poised to continue shaping the future of stroke research with a strong emphasis on personalized medicine. he aims to refine and implement his clot removal device selection algorithm into broader clinical practice. further integration of genetic biomarkers into real-time therapeutic decision-making is expected. his work not only improves outcomes for stroke patients but also sets a model for interdisciplinary research convergence, similar to how power electronics evolved by merging physics, control theory, and electrical engineering.

Notable Publication

  • Title: Relationship Between RNF213 p.R4810K and Echocardiographic Findings in Patients with Cerebrovascular Diseases: A Multicenter Prospective Cohort Study
    Author(s): Kotaro Noda, Yorito Hattori, Tatsuya Nishii, Yoshikazu Nakaoka, Masafumi Ihara
    Journal: Journal of the American Heart Association, 2025

  • Title: Deep learning-based post hoc denoising for 3D volume-rendered cardiac CT in mitral valve prolapse
    Author(s): Tatsuya Nishii, Tomoro Morikawa, Hiroki Nakajima, Satsuki M. Fukushima, Tetsuya Fukuda
    Journal: International Journal of Cardiovascular Imaging, 2025

  • Title: Evaluation of the Efficacy and Accuracy of Super-Flexible Three-Dimensional Heart Models of Congenital Heart Disease Made via Stereolithography Printing and Vacuum Casting: A Multicenter Clinical Trial
    Author(s): Isao Shiraishi, Masaaki Yamagishi, Takaya Hoashi, Toshiaki Hisada, Kenichi Kurosaki
    Journal: Journal of Cardiovascular Development and Disease, 2024

  • Title: Pericardial adhesion and performance of hemodynamically significant constrictive pericarditis using cine magnetic resonance feature tracking
    Author(s): Yasutoshi Ohta, Midori Fukuyama, Yoshiaki Morita, Hiroki Horinouchi, Tetsuya Fukuda
    Journal: International Journal of Cardiovascular Imaging, 2024

  • Title: Laterality of CT-measured hepatic extracellular volume fraction in patients with chronic thromboembolic pulmonary hypertension
    Author(s): Tatsuya Nishii, Hiroki Horinouchi, Takara Namboku, Takeshi Ogo, Tetsuya Fukuda
    Journal: International Journal of Cardiovascular Imaging, 2024

  • Title: Covering the intercostal artery branching of the Adamkiewicz artery during endovascular aortic repair increases the risk of spinal cord ischemia
    Author(s): Yoshimasa Seike, Tatsuya Nishii, Kazufumi Yoshida, Tetsuya Fukuda, Hitoshi Matsuda
    Journal: JTCVS Open, 2024

Dr. Evgenii Shumilov – Oncology and Hematology – Outstanding Scientist Award

Posted on by Innovator Awards

Dr. Evgenii Shumilov - Oncology and Hematology - Outstanding Scientist Award

University Hospital Münster Medical Clinic A -  Germany

Author Profile 

ORCID 

🎓 Early academic pursuits

Dr. Evgenii Shumilov began his academic journey in kirovskaya gebiet, russland, where he completed his general secondary education in june 2006. driven by a passion for human biology and clinical care, he enrolled in the staatliche medizinische akademie in kirow in 2006. the following year, he transitioned to the esteemed st. petersburger staatliche medizinische universität i.p. pawlow, where he pursued his degree in human medicine until 2012. during this formative period, he developed a growing interest in the biochemical pathways influencing addiction, which would later shape his doctoral research.

🏥 Professional endeavors

His professional career started immediately after his graduation with a clinical internship in internal medicine at the universitätsklinikum st. petersburg i.p. pawlow. dr. shumilov then completed a specialized clinical training in oncology at the renowned n.n. petrow institute for oncology. from 2015 to 2021, he continued his facharztausbildung (specialist training) in internal medicine, hematology, and oncology at the universitätsmedizin göttingen. since 2021, he has served in various capacities at the universitätsklinikum münster, advancing to oberarzt (senior physician) in the day clinic of oncology by 2022. his role requires the coordination of clinical therapies, implementation of modern diagnostics, and integration of interdisciplinary care — akin to the precision and optimization seen in power electronics systems.

🔬 Contributions and research focus

Dr. Shumilov has made significant scientific contributions in the field of pharmacology and hemato-oncology. between 2012 and 2015, he pursued a doctoral program in pharmacology at the anichkow institute for experimental medicine, focusing on neuropharmacology and the role of orexin-1 receptors in addiction — a study that mirrors the regulatory mechanisms of feedback and control in power electronics. in 2018, he earned a second doctorate (dr. med.) from the university of bern, switzerland, with a dissertation exploring genetic mutations bridging Oncology and Hematology hematopoietic lineages and solid tumors in the age of high-throughput sequencing. his work has helped redefine diagnostic paradigms in clinical oncology.

🌍 Impact and influence

Dr. Shumilov’s cross-disciplinary expertise bridges clinical practice and molecular diagnostics. his innovative thinking, reflected in his dual doctoral research and international academic Oncology and Hematology exposure, positions him as a leader in precision medicine. like the transformative role of power electronics in renewable energy systems, his influence lies in optimizing diagnostic accuracy and tailoring therapies for oncology patients. he is actively mentoring junior clinicians, integrating translational research into routine care, and contributing to academic networks across europe and russia.

📚 Academic citations and recognitions

He has received notable academic recognition, including a posterpreis at the dgho annual meeting in stuttgart (2017), and the prestigious dfg “clinician scientist” funding from 2020 to 2021. his scientific contributions are frequently cited in studies on neuropharmacology and next-generation sequencing diagnostics. his work on orexin receptors and hematologic malignancies Oncology and Hematology continues to influence both pharmacologic models and clinical protocols.

🌱 Legacy and future contributions

Dr. Shumilov’s legacy lies in his capacity to interweave basic science with clinical oncology. he is currently leading projects that integrate high-throughput genomic data with patient-specific therapy plans, aiming for breakthroughs in hematologic and solid tumor treatments. with a forward-looking perspective, he is exploring digital integration and ai-assisted diagnostics, similar to how power electronics revolutionize control in automated systems. his future vision includes strengthening international research collaborations and expanding educational programs for medical scientists.

Notable Publications 

  • Title: Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma
    Author(s): Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib, Paolo Mazzeo, Rebecca Wurm-Kuczera, Vladan Vucinic, Udo Holtick, Hristo Boyadzhiev, Thomas Melchardt, Alexander Sebastian Hölscher, et al.
    Journal: Blood Advances

  • Title: Allogeneic stem cell transplantation against aggressive lymphomas: graft-versus-lymphoma effects in peripheral T-cell lymphoma and diffuse large B-cell lymphoma after myeloablative conditioning
    Author(s): Evgenii Shumilov, Lena Levien, Paolo Mazzeo, Wolfram Jung, Andreas Leha, Raphael Koch, Justin Hasenkamp, Gerald Wulf
    Journal: Leukemia & Lymphoma

  • Title: Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study
    Author(s): Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff, Meng Wang, Thomas Melchardt, Udo Holtick, Ulrike Bacher, Philipp B. Staber, Paolo Mazzeo, Corinna Leng, et al.
    Journal: Blood Advances

  • Title: Benefit of repeated COVID‐19 vaccination for patients with B‐cell malignancies
    Author(s): Ulrike Bacher, Evgenii Shumilov, Thomas Pabst
    Journal: British Journal of Haematology

  • Title: Radiotherapy in Combination with Systemic Therapy for Multiple Myeloma—A Critical Toxicity Evaluation in the Modern Treatment Era
    Author(s): Michael Oertel, Tom Schlusemann, Evgenii Shumilov, Gabriele Reinartz, Anne Bremer, Stephan Rehn, Georg Lenz, Cyrus Khandanpour, Hans Theodor Eich
    Journal: Cancers

Prof. Mrinal k ghosh  – Cancer Therapy – Outstanding Scientist Award

Posted on by Innovator Awards

Prof. Mrinal k ghosh  - Cancer Therapy - Outstanding Scientist Award

CSIR-Indian Institute of Chemical Biology - India 

Author Profile 

SCOPUS 

🎓 Early academic pursuits

Dr. Mrinal k ghosh earned his b.sc., m.sc., and phd in biochemistry from the university of calcutta, india. his academic journey was characterized by a strong foundation in molecular biology and biochemistry, leading to a prolific research career in cancer biology and inflammatory disorders.

🏢 Professional endeavors

Dr. Ghosh has held various prestigious positions at csir-indian institute of chemical biology, culminating in his current role as chief scientist. his international experience includes post-doctoral research at the cleveland clinic foundation, usa, and academic roles in india, contributing significantly to cancer research and molecular biology.

🔄 Contributions and research focus

Specializing in cancer biology and inflammatory disorders, dr. ghosh has developed groundbreaking research in signal transduction in cancer and stem cells. his work has led to numerous Cancer Therapy publications, patents, and collaborative projects that have advanced the understanding and treatment of cancer.

🏆 Accolades and recognition

His numerous accolades include the bharat vikash award, fellowships from the national academy of science and technology, and the outstanding scientist award. his role as a reviewer for top Cancer Therapy journals and evaluator for national and international projects further highlights his academic stature.

👨‍👩‍👦 Impact and influence

Dr. Ghosh's influence extends beyond his research, impacting policy-making, academic standards, and translational research in india. his leadership roles within csir-iicb and various academic Cancer Therapy committees have shaped the future of scientific research in the country.

🌟 Legacy and future contributions

Dr. Ghosh's legacy is defined by his contributions to cancer biology, his mentorship of future scientists, and his commitment to advancing biomedical research. his ongoing work promises continued innovation and significant contributions to cancer therapy and molecular biology.

Notable Publications 

  • Title: The key vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer
    Author(s): Gouranga Saha, Mrinal Kanti Ghosh
    Journal: BBA - Molecular Cell Research, 2025

  • Title: Phenolato and alkoxo promoted change in the ligand coordination mode in a four-membered ortho-metalated ruthenium(II) organometallics
    Author(s): Mrinal Kanti Ghosh, Jagannath Chowdhury, Purnananda Garu, Indranil Chakraborty, Swarup Chattopadhyay
    Journal: Polyhedron, 2025

  • Title: Carbon Nanotubes in Cancer Diagnosis and Treatment: Current Trends and Future Perspectives
    Author(s): Sunny Kumar, Aafreen Ansari, Malini Basu, Sabana Begam, Mrinal Kanti Ghosh
    Journal: Advanced Therapeutics, 2025

  • Title: E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities
    Author(s): Sunny Kumar, Malini Basu, Mrinal Kanti Ghosh
    Journal: BBA - Molecular Cell Research, 2024

  • Title: Chromosomal instability (CIN) triggers immune evasion and metastatic potential in cancer through rewired STING signalling
    Author(s): Mrinal Kanti Ghosh, Srija Roy
    Journal: Molecular Biomedicine, 2024